“Combined Immune-Mediated Adverse Events in Treatment With Immune Checkpoint Inhibitors”. Voprosy Onkologii, vol. 68, no. 6, Dec. 2022, pp. 846-53, https://doi.org/10.37469/0507-3758-2022-68-6-846-853.